英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

triarch    
三原型

三原型


请选择你想看的字典辞典：
单词字典翻译
triarch查看　triarch　在百度字典中的解释百度英翻中〔查看〕
triarch查看　triarch　在Google字典中的解释Google英翻中〔查看〕
triarch查看　triarch　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV . . .
    FOSTER CITY, Calif --(BUSINESS WIRE)-- Gilead Sciences, Inc (Nasdaq: GILD) today announced that the U S Food and Drug Administration (FDA) has approved Yeztugo ® (lenacapavir)—the company’s injectable HIV-1 capsid inhibitor—as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV in adults and adolescents weighing at least 35kg, making it the first and only twice
  • FDA Approves Yeztugo for HIV PrEP Lasting 6 Months
    The FDA approved lenacapavir (Yeztugo, Gilead Sciences), an injectable HIV-1 capsid inhibitor, to be used as pre-exposure prophylaxis to reduce the risk for sexually acquired HIV in adults and adolescents weighing at least 35 kg, making it the first and only twice-yearly option for Americans who need or want PrEP Data show that almost 100% of
  • US FDA approves HIV prevention drug: Why is this a breakthrough?
    The Lenacapavir injection — sold as Yeztugo by pharmaceutical giant Gilead — was approved based on the results of two Phase 3 trials that showed 99 9% of individuals remained HIV negative with the two shots taken annually (Representative File)
  • Not a licence to be wild | News | Jamaica Gleaner
    Yestugo (lenocapavir), manufactured by US-based verology company Gilead Sciences, last week became the first FDA-approved HIV prevention drug offering up to six months of potection Distribution in the US is expected within the next few months, with international availability anticipated once additional regulatory approvals are secured
  • FDA approves breakthrough HIV drug with 96% risk reduction - Advocate. com
    Gilead's Yeztugo, generic name lenacapavir (LEN), has been approved for prevention after highly successful trials in September found that it nearly eliminated the spread of the virus among
  • RISE IN SOME VISITS - PressReader
    Yestugo (lenocapavi­r), manufactur­ed by US-based verology company Gilead Sciences, last week became the first FDA-approved HIV prevention drug offering up to six months of potection Distributi­on in the US is expected within the next few months, with internatio­nal availabili­ty anticipate­d once additional regulatory approvals are secured
  • Gilead HIV shot wins FDA approval - LinkedIn
    The new Yestugo (lenacapavir) has the ability to prevent 99% of new HIV cases with a TWICE a YEAR injection That is a cause for celebration
  • Food and Drug Administration
    Food and Drug Administration
  • FDA Purplebook
    The Purple Book database contains information on all FDA-licensed (approved) biological products regulated by the Center for Drug Evaluation and Research (CDER), including licensed biosimilar
  • Es un día histórico: EU aprueba el Yeztugo, un . . . - Periódico AM
    La Administración de Alimentos y Medicamentos de Estados Unidos (FDA) aprobó un nuevo tratamiento para prevenir el VIH, anunció este miércoles el laboratorio farmacéutico Gilead, que lo desarrolla "Este es un día histórico", declaró Daniel O'Day, presidente y director ejecutivo de la compañía





中文字典-英文字典  2005-2009